
• The US
• Canada
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pet Biotics Market Snapshot
Chapter 4. Global Pet Biotics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2026-2035
4.8. Global Pet Biotics Market Penetration & Growth Prospect Mapping (US$ Mn), 2022-2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Use/impact of AI on PET BIOTICS Industry Trends
Chapter 5. Pet Biotics Market Segmentation 1: By Product Type, Estimates & Trend Analysis
5.1. Market Share By Product Type, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Product Type:
5.2.1. Probiotics Bacteria
5.2.1.1. Lactobacillus
5.2.1.2. Bifidobacterium
5.2.1.3. Bacillus
5.2.1.4. Enterococcus
5.2.1.5. Streptococcus Thermophilus
5.2.1.6. Yeast & Fungi
5.2.1.6.1. Saccharomyces Boulardii
5.2.1.6.2. Saccharomyces Cerevisiae
5.2.1.6.3. Other Yeast & Fungi
5.2.2. Prebiotics Bacteria
5.2.2.1. Oligosaccharides
5.2.2.2. Fructooligosaccharides (Fos)
5.2.2.3. Galactooligosaccharides (Gos)
5.2.2.4. Mannanoligosaccharides (Mos)
5.2.2.5. Other Oligosaccharides
5.2.2.5.1. Inulin
5.2.2.5.2. Polydextrose
5.2.2.6. Other Prebiotic Ingredient Types (Beta-Glucans, Resistant Starches, Pectin)
5.2.3. Postbiotics Bacteria
5.2.3.1. Lactobacillus
5.2.3.2. Bifidobacterium
5.2.3.3. Other Bacteria
5.2.3.4. Yeast
5.2.3.5. Saccharomyces Boulardii
5.2.3.6. Saccharomyces Cerevisiae
Chapter 6. Pet Biotics Market Segmentation 4: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Application :
6.2.1. Dry Food
6.2.2. Wet Food
6.2.3. Supplements
6.2.4. Snacks & Treats
Chapter 7. Pet Biotics Market Segmentation 2: By Pet, Estimates & Trend Analysis
7.1. Market Share by Pet, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Pet:
7.2.1. Dogs
7.2.2. Cats
7.2.3. Other Pets (Birds, Equine, And Other Small Mammals)
Chapter 8. Pet Biotics Market Segmentation 2: By Form, Estimates & Trend Analysis
8.1. Market Share by Form, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Form:
8.2.1. Dry
8.2.2. Liquid
Chapter 9. Pet Biotics Market Segmentation 2: By Function, Estimates & Trend Analysis
9.1. Market Share by function, 2025 & 2035
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following function:
9.2.1. Digestive/Gut Health
9.2.2. Immune Modulation
9.2.3. Metabolic & Weight Management
9.2.4. Oral & Dental Health
9.2.5. Other Functions
Chapter 10. Pet Biotics Market Segmentation 2: By Manufacturing Technology, Estimates & Trend Analysis
10.1. Market Share by Manufacturing Technology, 2025 & 2035
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Manufacturing Technology:
10.2.1. Fermentation
10.2.2. Centrifugation & Filtration
10.2.3. Drying & Stabilization
10.2.4. Encapsulation & Protection
10.2.5. Inactivation & Cell Disruption
10.2.6. Formulation & Blending
10.2.7. Quality Control & Storage
Chapter 11. Pet Biotics Market Segmentation 5: Regional Estimates & Trend Analysis
11.1. Global Pet Biotics Market, Regional Snapshot 2025 & 2035
11.2. North America
11.2.1. North America Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
11.2.1.1. US
11.2.1.2. Canada
11.2.2. North America Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts By Product Type, 2022-2035
11.2.3. North America Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Pet, 2022-2035
11.2.4. North America Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2035
11.2.5. North America Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Function, 2022-2035
11.2.6. North America Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Form, 2022-2035
11.2.7. North America Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Technology, 2022-2035
11.3. Europe
11.3.1. Europe Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
11.3.1.1. Germany
11.3.1.2. U.K.
11.3.1.3. France
11.3.1.4. Italy
11.3.1.5. Spain
11.3.1.6. Rest of Europe
11.3.2. Europe Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts By Product Type, 2022-2035
11.3.3. Europe Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Pet, 2022-2035
11.3.4. Europe Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2035
11.3.5. Europe Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Function, 2022-2035
11.3.6. Europe Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Form, 2022-2035
11.3.7. Europe Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Technology, 2022-2035
11.4. Asia Pacific
11.4.1. Asia Pacific Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
11.4.1.1. India
11.4.1.2. China
11.4.1.3. Japan
11.4.1.4. Australia
11.4.1.5. South Korea
11.4.1.6. Hong Kong
11.4.1.7. Southeast Asia
11.4.1.8. Rest of Asia Pacific
11.4.2. Asia Pacific Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts By Product Type, 2022-2035
11.4.3. Asia Pacific Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Pet, 2022-2035
11.4.4. Asia Pacific Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2035
11.4.5. Asia Pacific Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Form, 2022-2035
11.4.6. Asia Pacific Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Function, 2022-2035
11.4.7. Asia Pacific Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Technology, 2022-2035
11.5. Latin America
11.5.1. Latin America Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
11.5.1.1. Brazil
11.5.1.2. Mexico
11.5.1.3. Rest of Latin America
11.5.2. Latin America Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts By Product Type, 2022-2035
11.5.3. Latin America Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Pet, 2022-2035
11.5.4. Latin America Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2035
11.5.5. Latin America Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Form, 2022-2035
11.5.6. Latin America Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Function, 2022-2035
11.5.7. Latin America Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Technology, 2022-2035
11.6. Middle East & Africa
11.6.1. Middle East & Africa Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2035
11.6.1.1. GCC Countries
11.6.1.2. Israel
11.6.1.3. South Africa
11.6.1.4. Rest of Middle East and Africa
11.6.2. Middle East & Africa Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts By Product Type, 2022-2035
11.6.3. Middle East & Africa Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Pet, 2022-2035
11.6.4. Middle East & Africa Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2035
11.6.5. Middle East & Africa Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Form, 2022-2035
11.6.6. Middle East & Africa Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Function, 2022-2035
11.6.7. Middle East & Africa Pet Biotics Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Technology, 2022-2035
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. ADM (US)
12.2.1.1. Business Overview
12.2.1.2. Key Product/Service
12.2.1.3. Financial Performance
12.2.1.4. Geographical Presence
12.2.1.5. Recent Developments with Business Strategy
12.2.2. Alltech (US)
12.2.3. dsm-firmenich (Netherlands)
12.2.4. International Flavors & Fragrances Inc. (US)
12.2.5. Kerry Group plc (Ireland)
12.2.6. Cargill, Incorporated (US)
12.2.7. Probi (Sweden)
12.2.8. Kemin Industries, Inc. (US)
12.2.9. BENEO GmbH (Germany)
12.2.10. Ingredion (US)
12.2.11. Lallemand Inc. (Canada)
12.2.12. Sacco System (Italy)
12.2.13. Phileo by Lesaffre (France)
12.2.14. Sanzyme Biologics (India)
12.2.15. Orffa (Netherlands)
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.